Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Argus Health
Farmers Insurance
Express Scripts
US Army
Baxter
Moodys
Healthtrust
AstraZeneca
Harvard Business School

Generated: January 17, 2018

DrugPatentWatch Database Preview

Penciclovir - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for penciclovir and what is the scope of penciclovir freedom to operate?

Penciclovir
is the generic ingredient in one branded drug marketed by Mylan Pharms Inc and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Penciclovir has one hundred and five patent family members in thirty-four countries.

There are two drug master file entries for penciclovir. Four suppliers are listed for this compound.
Pharmacology for penciclovir

US Patents and Regulatory Information for penciclovir

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc DENAVIR penciclovir CREAM;TOPICAL 020629-001 Sep 24, 1996 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc DENAVIR penciclovir CREAM;TOPICAL 020629-001 Sep 24, 1996 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for penciclovir

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Pharms Inc DENAVIR penciclovir CREAM;TOPICAL 020629-001 Sep 24, 1996 ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc DENAVIR penciclovir CREAM;TOPICAL 020629-001 Sep 24, 1996 ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc DENAVIR penciclovir CREAM;TOPICAL 020629-001 Sep 24, 1996 ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc DENAVIR penciclovir CREAM;TOPICAL 020629-001 Sep 24, 1996 ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc DENAVIR penciclovir CREAM;TOPICAL 020629-001 Sep 24, 1996 ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc DENAVIR penciclovir CREAM;TOPICAL 020629-001 Sep 24, 1996 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for penciclovir

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,886,215 2-acetoxymethyl-4-halo-butyl-1-yl acetates ➤ Subscribe
5,075,445 Guanine derivatives ➤ Subscribe
6,573,378 Antiviral guanine derivatives ➤ Subscribe
5,246,937 Purine derivatives ➤ Subscribe
6,187,922 Process for the preparation of purine derivatives ➤ Subscribe
5,684,153 Process for the preparation of purine derivatives ➤ Subscribe
5,250,688 Purine derivatives ➤ Subscribe
6,388,074 Process for the preparation of purine derivatives ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for penciclovir

Supplementary Protection Certificates for penciclovir

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB96/014 United Kingdom ➤ Subscribe SPC/GB96/014: 20040810, EXPIRES: 20090809
C0015 Belgium ➤ Subscribe PRODUCT NAME: PENCICLOVIR; NAT. REGISTRATION NO/DATE: NL 21 303 19980415; FIRST REGISTRATION: GB - 10592/0078 19960228
C0033 Belgium ➤ Subscribe PRODUCT NAME: PENCICLOVIR; NAT. REGISTRATION NO/DATE: 981 IS 110 F 7; 19970206; FIRST REGISTRATION: GB 10592/0078 19960228
C/GB94/002 United Kingdom ➤ Subscribe SPC/GB94/002: 20050910, EXPIRES: 20081209
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Chubb
AstraZeneca
Colorcon
Johnson and Johnson
Fuji
Farmers Insurance
Chinese Patent Office
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot